Patient's age, timing of cannulation (<4 days vs ≥4 days from intubation), and use
of inotropes and vasopressors are essential factors to consider when analysing the
outcomes of patients receiving ECMO for COVID-19. Despite post-discharge survival
being favourable, persisting long-term symptoms suggest that dedicated post-ECMO follow-up
programmes are required.